Symphogen
Symphogen is the Servier Group's Antibody Center of Excellence.
Symphogen
Symphogen is the Servier Group's Antibody Center of Excellence. Symphogen was founded in 2000 and became part of the Servier Group in June 2020 to support Servier's commitment to improving patient health and its R&D strategy in oncology and immuno-oncology. Symphogen is a R&D organization with approximately ~150 employees located in Ballerup, Denmark. Servier is a global pharmaceutical group governed by a non-profit foundation and dedicated to four therapeutic areas: oncology, cardio metabolism & veinous diseases, neuroscience, and immuno-inflammation. Servier is present in 150 countries, employs 21,900 people worldwide and has total revenues of 5.3 billion euros in 2022/23.
What we do and why we do it
As a PhD student at Symphogen, you will be part of a dedicated and passionate team developing antibody therapeutics in oncology and immuno-oncology. As Servier's Antibody Center of Excellence, Symphogen represents cutting-edge antibody technologies and competencies essential to identify the best drug candidates, advance them into the clinic, and ultimately improve the lives of patients worldwide.
Working as a PhD at Symphogen
Symphogen offers an innovative and flexible workplace with an inspiring and inclusive culture, a strong focus on employee well-being, and great opportunities for personal development. You will have passionate and competent colleagues with lots of open dialogue, knowledge sharing, agility, empowerment, and fun.